Revenue Growth (YoY)
Updated 296h ago
Sector Performance
2th percentileFOXA
-8.6%
Sector Median
7.9%
Sector Avg
11.7%
Deep Analysis
Revenue growth year-over-year (YoY) measures the change in sales from the same quarter one year ago.
A -8.6% rate means FOXA's revenue has declined by that percentage versus the prior year. Among sector peers, the median is 7.8% positive growth, and FOXA sits at the 3rd percentile — meaning 97% of peers have stronger revenue growth. The metric shows no trend data: the YoY change and quarter-over-quarter change are both reported as N/A, and the only historical value is the current -8.6%. With a low level and no available trend, the investment risk is elevated due to the sharp decline versus peers, but the lack of movement makes the opportunity unclear. This -8.6% figure directly contradicts the NEUTRAL verdict, as such a weak performance relative to peers would typically warrant a more cautious view. However, the absence of trend information leaves the overall rating unchanged.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about FOXA?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are FOXA's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: FMC (-4.1%), COP (-4.6%), CCI (-4.8%), EMN (-4.9%), IPG (-5.1%).
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master FOXA's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full FOXA research report →FOXA
-8.6%
Sector Median
7.9%
Sector Avg
11.7%
How FOXA's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.